Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-24 @ 2:53 PM
NCT ID:
NCT01970059
Eligibility Criteria:
Inclusion Criteria:
* Males or Females
* Aged from 18 to 70 years
* Had a history of essential hypertension
* Average sitting diastolic blood pressure≧90mmHg，but≦109mmHg
Exclusion Criteria:
* Malignant hypertension
* Average sitting systolic blood pressure≧180mmHg
* Type 2 diabetes with hemoglobin A1c≥9%
* Type 1 diabetes
* New York Heart Association class Ⅱ-Ⅳ congestive heart-failure
* Unstable angina
* Second or third degree heart block or history of sick sinus syndrome unless a pacemaker was in place
* Atrial fibrillation
* Bradycardia (\<60 bpm, seated)
* Asthma or other obstructive pulmonary disease
* History of myocardial infarction
* Stroke in the 6 months before screening
* Known contraindications to β-adrenergic blocker therapy
* Glutamic-oxaloacetic transaminase and/or glutamic-pyruvic transaminase\>3 times upper limit of normal
* Crea\>2 times upper limit of normal
* Pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01970059
Study Brief:
Protocol Section:
NCT01970059